Testolactone
Term · Oncology and biomedicine · MLC-T-ONC-017078
A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels.
| Identifier | MLC-T-ONC-017078 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | TL |
| Synonyms | Fludestrin; therapeutic testolactone |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017078",
"term": "Testolactone",
"field": "Oncology and biomedicine",
"definition": "A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels.",
"abbreviation": "TL",
"synonyms": [
"Fludestrin",
"therapeutic testolactone"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/testolactone/"
}
Record 16,180 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.